Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The menopause, hormone replacement therapy and breast cancer.

The Journal of steroid biochemistry and molecular biology - 1 Dec 2002

Marsden Jo

Abstract excerpt

Concern exists that the reduction in breast cancer risk associated with the onset of the menopause will be negated with exposure to hormone replacement therapy (HRT). Evidence from large-scale randomised HRT trials support observational data that have shown a modest increase in breast cancer risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Breast Neoplasms
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estradiol

Share to Hormone Replacement Therapy

Share to Menopause

Share to Time Factors

Source

Identifiers

PMID: 12650709
DOI: 10.1016/s0960-0760(02)00258-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-12650709-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The menopause, hormone replacement therapy and breast cancer.PMID 12650709Read ↗

Hormone replacement and breast cancer.Semantic proximity Read ↗

The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.Semantic proximity Read ↗

Breast cancer prevention: present and future.Semantic proximity Read ↗

Is HRT justified for symptom management in women at higher risk of developing breast cancer?Semantic proximity Read ↗

Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.Semantic proximity Read ↗

Hormone replacement therapy and elevated breast cancer risk: An artifact of growth acceleration?Semantic proximity Read ↗

Breast cancer and replacement therapy: which women are at risk?Semantic proximity Read ↗

Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

[Hormonal carcinogenesis in women: from mechanisms to prevention].Semantic proximity Read ↗

One effect and two causes: Growth acceleration and breast cancer risk after hormone replacement therapySemantic proximity Read ↗

Paradoxical Clinical Effect of Estrogen on Breast Cancer Risk: A “New” Biology of Estrogen-induced ApoptosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.